ALP 0 3 0 3 B-clinical_variable
≤ 4 5 4 5 O
5X 6 8 6 8 B-upper_bound
ULN 9 12 9 12 I-upper_bound
in 13 15 13 15 O
patients 16 24 16 24 O
with 25 29 25 29 O
bone 30 34 30 34 B-cancer
metastases 35 45 35 45 I-cancer

ALT 0 3 46 49 B-clinical_variable
≤ 4 5 50 51 O
2.5X 6 10 52 56 B-upper_bound
ULN 11 14 57 60 I-upper_bound

ANC 0 3 61 64 B-clinical_variable
≥ 4 5 65 66 O
1500 6 10 67 71 B-lower_bound
cells 11 16 72 77 I-lower_bound
/ 16 17 77 78 I-lower_bound
mm3 17 20 78 81 I-lower_bound

AST 0 3 82 85 B-clinical_variable
1.5 4 7 86 89 B-lower_bound
X 8 9 90 91 I-lower_bound
ULN 10 13 92 95 I-lower_bound

Adequate 0 8 96 104 O
bone 9 13 105 109 O
marrow 14 20 110 116 O
function 21 29 117 125 O
as 30 32 126 128 O
indicated 33 42 129 138 O
by 43 45 139 141 O
the 46 49 142 145 O
following 50 59 146 155 O
, 59 60 155 156 O
within 61 67 157 163 O
14 68 70 164 166 B-upper_bound
days 71 75 167 171 I-upper_bound
of 76 78 172 174 O
enrollment 79 89 175 185 O

Adequate 0 8 186 194 O
hemostatic 9 19 195 205 O
function 20 28 206 214 O
as 29 31 215 217 O
determined 32 42 218 228 O
by 43 45 229 231 O
PT 46 48 232 234 B-clinical_variable
, 48 49 234 235 O
INR 50 53 236 239 B-clinical_variable
and 54 57 240 243 O
aPTT 58 62 244 248 B-clinical_variable
< 63 64 249 250 O
1.5X 65 69 251 255 B-upper_bound
ULN 70 73 256 259 I-upper_bound
( 74 75 260 261 O
unless 75 81 261 267 O
on 82 84 268 270 O
therapeutic 85 96 271 282 O
coagulation 97 108 283 294 O
, 108 109 294 295 O
in 110 112 296 298 O
which 113 118 299 304 O
case 119 123 305 309 O
the 124 127 310 313 O
adequate 128 136 314 322 O
level 137 142 323 328 O
of 143 145 329 331 O
anticoagulation 146 161 332 347 O
will 162 166 348 352 O
be 167 169 353 355 O
determined 170 180 356 366 O
by 181 183 367 369 O
the 184 187 370 373 O
investigator 188 200 374 386 O
) 200 201 386 387 O

Adequate 0 8 388 396 O
liver 9 14 397 402 O
function 15 23 403 411 O
, 23 24 411 412 O
as 25 27 413 415 O
indicated 28 37 416 425 O
by 38 40 426 428 O
the 41 44 429 432 O
following 45 54 433 442 O
, 54 55 442 443 O
within 56 62 444 450 O
14 63 65 451 453 B-upper_bound
days 66 70 454 458 I-upper_bound
of 71 73 459 461 O
enrollment 74 84 462 472 O

Age 0 3 473 476 B-age
> 4 5 477 478 O
18 6 8 479 481 B-lower_bound
years 9 14 482 487 I-lower_bound

Agreement 0 9 488 497 O
by 10 12 498 500 O
the 13 16 501 504 O
patient 17 24 505 512 O
and/or 25 31 513 519 O
partner 32 39 520 527 O
to 40 42 528 530 O
use 43 46 531 534 B-contraception_consent
highly 47 53 535 541 I-contraception_consent
effective 54 63 542 551 I-contraception_consent
, 63 64 551 552 I-contraception_consent
nonhormonal 65 76 553 564 I-contraception_consent
form 77 81 565 569 I-contraception_consent
of 82 84 570 572 I-contraception_consent
contraception 85 98 573 586 I-contraception_consent
or 99 101 587 589 I-contraception_consent
two 102 105 590 593 I-contraception_consent
effective 106 115 594 603 I-contraception_consent
forms 116 121 604 609 I-contraception_consent
of 122 124 610 612 I-contraception_consent
non 125 128 613 616 I-contraception_consent
- 128 129 616 617 I-contraception_consent
hormonal 129 137 617 625 I-contraception_consent
contraception 138 151 626 639 I-contraception_consent

Brain 0 5 640 645 B-cancer
metastasis 6 16 646 656 I-cancer
is 17 19 657 659 O
allowed 20 27 660 667 O
if 28 30 668 670 O
previously 31 41 671 681 O
treated 42 49 682 689 O
, 49 50 689 690 O
stable 51 57 691 697 O
and 58 61 698 701 O
off 62 65 702 705 O
steroids 66 74 706 714 O
for 75 78 715 718 O
a 79 80 719 720 O
minimum 81 88 721 728 O
of 89 91 729 731 O
56 92 94 732 734 B-lower_bound
days 95 99 735 739 I-lower_bound

ECOG 0 4 740 744 B-clinical_variable
performance 5 16 745 756 I-clinical_variable
status 17 23 757 763 I-clinical_variable
0 24 25 764 765 B-lower_bound
- 25 26 765 766 O
2 26 27 766 767 B-upper_bound

More 0 4 768 772 O
than 5 9 773 777 O
3 10 11 778 779 B-lower_bound
prior 12 17 780 785 O
lines 18 23 786 791 O
of 24 26 792 794 O
endocrine 27 36 795 804 B-treatment
therapy 37 44 805 812 I-treatment
in 45 47 813 815 O
the 48 51 816 819 O
metastatic 52 62 820 830 O
setting 63 70 831 838 O

More 0 4 839 843 O
than 5 9 844 848 O
one 10 13 849 852 O
prior 14 19 853 858 O
line 20 24 859 863 O
of 25 27 864 866 O
chemotherapy 28 40 867 879 B-treatment
in 41 43 880 882 O
the 44 47 883 886 O
metastatic 48 58 887 897 O
setting 59 66 898 905 O

Patients 0 8 906 914 O
may 9 12 915 918 O
be 13 15 919 921 O
pre- 16 20 922 926 O
or 21 23 927 929 O
post 24 28 930 934 O
- 28 29 934 935 O
menopausal 29 39 935 945 O
; 39 40 945 946 O
pre 41 44 947 950 O
- 44 45 950 951 O
menopausal 45 55 951 961 O
patients 56 64 962 970 O
must 65 69 971 975 O
be 70 72 976 978 O
on 73 75 979 981 O
ovarian 76 83 982 989 B-treatment
suppression 84 95 990 1001 I-treatment
and 96 99 1002 1005 O
must 100 104 1006 1010 O
be 105 107 1011 1013 O
adequately 108 118 1014 1024 O
suppressed 119 129 1025 1035 O
on 130 132 1036 1038 O
LHRH 133 137 1039 1043 O
agonists 138 146 1044 1052 O
with 147 151 1053 1057 O
estradiol 152 161 1058 1067 O
levels 162 168 1068 1074 O
in 169 171 1075 1077 O
the 172 175 1078 1081 O
post 176 180 1082 1086 O
- 180 181 1086 1087 O
menopausal 181 191 1087 1097 O
range 192 197 1098 1103 O

Patients 0 8 1104 1112 O
may 9 12 1113 1116 O
have 13 17 1117 1121 O
been 18 22 1122 1126 O
previously 23 33 1127 1137 O
treated 34 41 1138 1145 O
with 42 46 1146 1150 O
an 47 49 1151 1153 O
mTOR 50 54 1154 1158 B-treatment
inhibitor 55 64 1159 1168 I-treatment
or 65 67 1169 1171 O
other 68 73 1172 1177 O
investigational 74 89 1178 1193 O
agent 90 95 1194 1199 O
in 96 98 1200 1202 O
addition 99 107 1203 1211 O
to 108 110 1212 1214 O
an 111 113 1215 1217 O
aromatase 114 123 1218 1227 B-treatment
inhibitor 124 133 1228 1237 I-treatment

Patients 0 8 1238 1246 O
may 9 12 1247 1250 O
not 13 16 1251 1254 O
have 17 21 1255 1259 O
significant 22 33 1260 1271 O
concurrent 34 44 1272 1282 B-chronic_disease
illness 45 52 1283 1290 I-chronic_disease
, 52 53 1290 1291 O
infection 54 63 1292 1301 B-chronic_disease
, 63 64 1301 1302 O
pregnancy 65 74 1303 1312 B-pregnancy
or 75 77 1313 1315 O
lactation 78 87 1316 1325 O

Patients 0 8 1326 1334 O
must 9 13 1335 1339 O
have 14 18 1340 1344 O
histologically 19 33 1345 1359 O
or 34 36 1360 1362 O
cytologically 37 50 1363 1376 O
confirmed 51 60 1377 1386 O
invasive 61 69 1387 1395 O
breast 70 76 1396 1402 B-cancer
cancer 77 83 1403 1409 I-cancer
that 84 88 1410 1414 O
is 89 91 1415 1417 O
ER+ 92 95 1418 1421 B-clinical_variable
( 96 97 1422 1423 O
> 97 98 1423 1424 O
1 98 99 1424 1425 B-lower_bound
% 99 100 1425 1426 I-lower_bound
staining 101 109 1427 1435 O
) 109 110 1435 1436 O
with 111 115 1437 1441 O
radiographical 116 130 1442 1456 O
or 131 133 1457 1459 O
clinical 134 142 1460 1468 O
evidence 143 151 1469 1477 O
of 152 154 1478 1480 O
metastatic 155 165 1481 1491 B-cancer
disease 166 173 1492 1499 I-cancer

Patients 0 8 1500 1508 O
must 9 13 1509 1513 O
have 14 18 1514 1518 O
previously 19 29 1519 1529 O
received 30 38 1530 1538 O
palbociclib 39 50 1539 1550 B-treatment
in 51 53 1551 1553 O
the 54 57 1554 1557 O
adjuvant 58 66 1558 1566 B-treatment
, 66 67 1566 1567 O
neo 68 71 1568 1571 B-treatment
- 71 72 1571 1572 I-treatment
adjuvant 72 80 1572 1580 I-treatment
or 81 83 1581 1583 O
metastatic 84 94 1584 1594 B-treatment
setting 95 102 1595 1602 I-treatment

Patients 0 8 1603 1611 O
must 9 13 1612 1616 O
not 14 17 1617 1620 O
have 18 22 1621 1625 O
a 23 24 1626 1627 O
different 25 34 1628 1637 O
active 35 41 1638 1644 B-cancer
malignancy 42 52 1645 1655 I-cancer

Platelets 0 9 1656 1665 B-clinical_variable
≥ 10 11 1666 1667 O
100,000 12 19 1668 1675 B-lower_bound
cells/ 20 26 1676 1682 I-lower_bound
mm3 27 30 1683 1686 I-lower_bound

Premenopausal 0 13 1687 1700 O
patients 14 22 1701 1709 O
can 23 26 1710 1713 B-pregnancy
not 26 29 1713 1716 I-pregnancy
be 30 32 1717 1719 I-pregnancy
pregnant 33 41 1720 1728 I-pregnancy
and 42 45 1729 1732 O
must 46 50 1733 1737 O
agree 51 56 1738 1743 B-contraception_consent
to 57 59 1744 1746 I-contraception_consent
adequate 60 68 1747 1755 I-contraception_consent
birth 69 74 1756 1761 I-contraception_consent
control 75 82 1762 1769 I-contraception_consent
in 83 85 1770 1772 O
addition 86 94 1773 1781 O
to 95 97 1782 1784 O
ovarian 98 105 1785 1792 B-treatment
suppression 106 117 1793 1804 I-treatment

Prior 0 5 1805 1810 B-treatment
therapy 6 13 1811 1818 I-treatment
with 14 18 1819 1823 I-treatment
tamoxifen 19 28 1824 1833 I-treatment
in 29 31 1834 1836 I-treatment
the 32 35 1837 1840 I-treatment
metastatic 36 46 1841 1851 I-treatment
setting 47 54 1852 1859 I-treatment

Prior 0 5 1860 1865 B-treatment
treatment 6 15 1866 1875 I-treatment
with 16 20 1876 1880 I-treatment
tamoxifen 21 30 1881 1890 I-treatment
is 31 33 1891 1893 O
allowed 34 41 1894 1901 O
in 42 44 1902 1904 O
the 45 48 1905 1908 O
adjuvant 49 57 1909 1917 O
setting 58 65 1918 1925 O
provided 66 74 1926 1934 O
that 75 79 1935 1939 O
it 80 82 1940 1942 O
was 83 86 1943 1946 O
followed 87 95 1947 1955 O
by 96 98 1956 1958 O
a 99 100 1959 1960 O
minimum 101 108 1961 1968 O
of 109 111 1969 1971 O
2 112 113 1972 1973 B-lower_bound
years 114 119 1974 1979 I-lower_bound
of 120 122 1980 1982 O
an 123 125 1983 1985 O
AI 126 128 1986 1988 O

The 0 3 1989 1992 O
minimum 4 11 1993 2000 O
duration 12 20 2001 2009 O
of 21 23 2010 2012 O
AI 24 26 2013 2015 B-treatment
in 27 29 2016 2018 O
the 30 33 2019 2022 O
adjuvant 34 42 2023 2031 O
setting 43 50 2032 2039 O
is 51 53 2040 2042 O
2 54 55 2043 2044 B-lower_bound
years 56 61 2045 2050 I-lower_bound

There 0 5 2051 2056 O
is 6 8 2057 2059 O
no 9 11 2060 2062 O
minimum 12 19 2063 2070 O
duration 20 28 2071 2079 O
of 29 31 2080 2082 O
AI 32 34 2083 2085 B-treatment
in 35 37 2086 2088 I-treatment
the 38 41 2089 2092 I-treatment
metastatic 42 52 2093 2103 I-treatment
setting 53 60 2104 2111 I-treatment
or 61 63 2112 2114 I-treatment
neoadjuvant 64 75 2115 2126 I-treatment
setting 76 83 2127 2134 I-treatment

Total 0 5 2135 2140 B-clinical_variable
bilirubin 6 15 2141 2150 I-clinical_variable
1.5upper 16 24 2151 2159 O
limit 25 30 2160 2165 O
of 31 33 2166 2168 O
normal 34 40 2169 2175 O
( 41 42 2176 2177 O
ULN 42 45 2177 2180 O
) 45 46 2180 2181 O

Washout 0 7 2182 2189 O
of 8 10 2190 2192 O
2 11 12 2193 2194 O
weeks 13 18 2195 2200 O
is 19 21 2201 2203 O
required 22 30 2204 2212 O
for 31 34 2213 2216 O
aromatase 35 44 2217 2226 B-treatment
inhibitors 45 55 2227 2237 I-treatment

cervical 0 8 2238 2246 B-chronic_disease
intraepithelial 9 24 2247 2262 I-chronic_disease
neoplasia 25 34 2263 2272 I-chronic_disease

creatinine 0 10 2273 2283 B-clinical_variable
≤ 11 12 2284 2285 O
1.5X 13 17 2286 2290 B-upper_bound
ULN 18 21 2291 2294 I-upper_bound

lkaline 0 7 2295 2302 B-clinical_variable
phosphatase 8 19 2303 2314 I-clinical_variable
≤ 20 21 2315 2316 O
2.5X 22 26 2317 2321 B-upper_bound
ULN 27 30 2322 2325 I-upper_bound

skin 0 4 2326 2330 B-cancer
basal 5 10 2331 2336 I-cancer
cell 11 15 2337 2341 I-cancer
carcinoma 16 25 2342 2351 I-cancer

skin 0 4 2352 2356 B-cancer
squamous 5 13 2357 2365 I-cancer
cell 14 18 2366 2370 I-cancer
carcinoma 19 28 2371 2380 I-cancer

